Unknown

Dataset Information

0

Artificial Intelligence Approach for Variant Reporting.


ABSTRACT: Purpose:Next-generation sequencing technologies are actively applied in clinical oncology. Bioinformatics pipeline analysis is an integral part of this process; however, humans cannot yet realize the full potential of the highly complex pipeline output. As a result, the decision to include a variant in the final report during routine clinical sign-out remains challenging. Methods:We used an artificial intelligence approach to capture the collective clinical sign-out experience of six board-certified molecular pathologists to build and validate a decision support tool for variant reporting. We extracted all reviewed and reported variants from our clinical database and tested several machine learning models. We used 10-fold cross-validation for our variant call prediction model, which derives a contiguous prediction score from 0 to 1 (no to yes) for clinical reporting. Results:For each of the 19,594 initial training variants, our pipeline generates approximately 500 features, which results in a matrix of > 9 million data points. From a comparison of naive Bayes, decision trees, random forests, and logistic regression models, we selected models that allow human interpretability of the prediction score. The logistic regression model demonstrated 1% false negativity and 2% false positivity. The final models' Youden indices were 0.87 and 0.77 for screening and confirmatory cutoffs, respectively. Retraining on a new assay and performance assessment in 16,123 independent variants validated our approach (Youden index, 0.93). We also derived individual pathologist-centric models (virtual consensus conference function), and a visual drill-down functionality allows assessment of how underlying features contributed to a particular score or decision branch for clinical implementation. Conclusion:Our decision support tool for variant reporting is a practically relevant artificial intelligence approach to harness the next-generation sequencing bioinformatics pipeline output when the complexity of data interpretation exceeds human capabilities.

SUBMITTER: Zomnir MG 

PROVIDER: S-EPMC6198661 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>Next-generation sequencing technologies are actively applied in clinical oncology. Bioinformatics pipeline analysis is an integral part of this process; however, humans cannot yet realize the full potential of the highly complex pipeline output. As a result, the decision to include a variant in the final report during routine clinical sign-out remains challenging.<h4>Methods</h4>We used an artificial intelligence approach to capture the collective clinical sign-out experience of  ...[more]

Similar Datasets

| S-EPMC8268222 | biostudies-literature
| S-EPMC7227517 | biostudies-literature
| S-EPMC8362955 | biostudies-literature
| S-EPMC8227070 | biostudies-literature
| S-EPMC7119286 | biostudies-literature
| S-EPMC3351754 | biostudies-other